Overcoming the Safety Challenges of Aldose Reductase Inhibition: Development of AT-001 for Diabetic Cardiomyopathy

Metabolism: Clinical and Experimental - Netherlands
doi 10.1016/j.metabol.2019.12.060
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search